Table 3.
Stage 2 high BP | Stage 1 high BP | Elevated BP | |
---|---|---|---|
ASCVD risk ≥10% | COR/LOE 1A | COR LOE 1A | Not recommended |
ASCVD risk <10% | COR LOE 1 C-LD | Not initially recommended | Not recommended |
Abbreviations: ACC, American College of Cardiology; AHA, American Heart Association; ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; COR, class of recommendation; LOE, level of evidence.
Nonpharmacologic lifestyle modifications recommended for all (COR LOE 1A). For older adults (65 years or older) with hypertension and a high burden of comorbidity and limited life expectancy, clinical judgment, patient preference, and a team-based approach to assess risk/benefit is reasonable for decisions regarding intensity of BP-lowering and choice of antihypertensive drugs (COR LOEIIa-CEO).